HomepageEarnings Events Newsdesk 2 hours ago Pfizer inc (PFE) TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer Pfizer inc (NYSE: PFE) FY 2026 Other Release AECOM (ACM) AECOM awarded position on $151-billion U.S. MDA SHIELD contract » « Eli Lilly and Company (LLY) Lilly's triple agonist, retatrutide, demonstrated significant reductions in A1C and weight in first Phase 3 trial for treatment of type 2 diabetes Newsdesk: